The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer

This publication has 9 references indexed in Scilit:

• Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial
  Journal of Clinical Oncology, 2015
• Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana’s predictive model
  Clinical and Translational Oncology, 2014
• Epidemiology of cancer-associated venous thrombosis
  Blood, 2013
• Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
  PLOS Medicine, 2012
• Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
  European Journal of Cancer, 2012
• A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
  Internal and Emergency Medicine, 2012
• Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
  New England Journal of Medicine, 2012
• Prediction of venous thromboembolism in cancer patients
  Blood, 2010
• Development and validation of a predictive model for chemotherapy-associated thrombosis
  Blood, 2008